Poliovirus infection of HeLa cells results in a rapid shutoff of host protein synthesis but does not inhibit the translation of poliovirus mRNA. It has been suggested that this virus-induced translational control is mediated by the inactivation of a cap binding protein (CBP) complex, and it has been shown that the 220,000-Da component(s) (p220) of the CBP complex is cleaved in infected HeLa cells to form antigenically related peptides of 100,000-130,000 Da. To determine whether the known viral protease (peptide 3C) was the mediator of the cleavage of p220, we used immunoblot techniques to analyze partially purified infected HeLa cell extracts for cleavage activity. We report here that p220 cleavage activity does not copurify with viral peptide 3C or with any precursors containing 3C sequences. We also show that cleavage of p220 can be demonstrated in vitro in HeLa cell extracts under conditions where the functional activity of the poliovirus protease is inhibited by specific antibody.
Poliovirus infection of HeLa cells induces a rapid and complete inhibition of host cell protein synthesis (1) . Experiments with fractionated extracts from poliovirus-infected HeLa ceils have shown that the ribosomal salt wash (RSW) from infected cells, which contains protein synthesis initiation factors, did not support translation of host or other capped mRNAs in vitro but did stimulate translation of poliovirus mRNA (2) (3) (4) . All other infected cell fractions did function in the translation of capped mRNAs in this system. Thus, of the components of the cellular translational machinery, only initiation factors seem to be altered by poliovirus infection.
Purification and analysis of individual initiation factors has implicated the cap binding protein (CBP) complex (also called CBP II or eIF-4F) as the defective component in poliovirusinfected cells (5) (6) (7) (8) . This multisubunit protein is required for formation of ribosome initiation complexes with capped mRNAs. Presumably, poliovirus mRNA, which is not capped, initiates translation via a cap-independent mechanism. A CBP complex has been purified from rabbit reticulocytes by workers in three laboratories, and it has been isolated as a complex of at least three polypeptides of 24,000, 46,000-50,000, and 200,000-220,000 Da (5) (6) (7) . The smallest component of this complex (24,000 Da) was specifically crosslinked to the labeled cap group of oxidized mRNA, which confirmed its identity with the 24,000-Da cap binding protein (CBP I) described previously (5, 6, 9) . The 46,000-Da component is eIF-4A or a variant of eIF-4A (6, 7) . The largest component of the CBP complex (termed p220) appears to be required for activity, but its precise function has not been characterized. Purified CBP complex can restore translation of capped mRNAs in poliovirus-infected cell extracts (5-7), providing strong evidence that only CBP complex is altered by virus infection.
By use of a specific [3H]m7Gppp mRNA crosslinking assay, Hansen et al. (10) showed that the 24,000-Da CBP I component of CBP complex is found predominantly in a rapidly sedimenting form in uninfected cells and only in a slowly sedimenting form in poliovirus-infected cells, suggesting that virus infection leads to the disruption of the protein complex.
Etchison et al. (11) used antiserum prepared against a preparation of eIF-3 that also contained CBP complex. Immunoblot analysis of HeLa cell proteins with this reagent showed that p220 could readily be detected in uninfected cells, but p220 was not present in infected cells. Instead, other antigenically related peptides of 100,000-130,000 Da were detected. Presumably, these smaller peptides represent cleavage products of p220 and these data support the hypothesis that CBP complex is defective in infected cells. These authors also reported a temporal correlation between the inhibition of host protein synthesis and the degradation of p220 in infected HeLa cells. Therefore, specific cleavage of p220 was suggested as the cause of the dissociation and inactivation of CBP in poliovirus-infected cells.
The poliovirus genome is known to code for at least one protease involved in processing precursor polypeptides to functional viral proteins (12) . Antiserum to protein 3C [nomenclature according to Rueckert and Wimmer (13) ; formerly called P3-7c] specifically inhibited processing at GlnGly residues in vitro, and thus the activity responsible for these cleavages likely resides in the amino acid sequences contained in 3C (12) . The antiserum also reacts with 3CD (P3-2) and 3C' (P3-6a), two viral polypeptides NH2-coterminal with 3C, and it is not known how many or which of these polypeptides manifest protease activity. The observation that the cellular protein p220, involved in capdependent translation, is proteolytically cleaved in poliovirus-infected cells has led to the suggestion that the viral protease 3C might be responsible for the cleavage and thus might be the direct viral mediator of the virus-induced inhibition of host cell protein synthesis (14) . In this study, we tested this hypothesis, and we report that the viral protease 3C does not copurify with the p220 cleavage activity. We also demonstrate that the in vitro cleavage of p220 occurs under conditions in which the functional activity of the poliovirus protease is inhibited by specific antibody.
MATERIALS AND METHODS
Cells and Virus. HeLa S3 cells were grown in spinner cultures in Joklik's modified minimum essential medium supplemented with 7% calf serum. The growth and purificaAbbreviations: CBP complex, cap binding protein complex; RSW, ribosomal salt wash.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. tion of poliovirus type 1 (Mahoney strain) has been described (15 The protein sample was applied to a P-1l phosphocellulose (Whatman) column (1.5 x 4 cm) and eluted in steps with the same buffer containing 10 mM KCl, 100 mM KCl, and 500 mM KCL. The eluted fractions were dialyzed against the starting phosphate buffer (10 mM KCl) before assay and analysis.
Antibody and Imnmunoblot Analysis. Monoclonal antibody directed against p220 was isolated from a hybridoma that was prepared as a mouse ascites tumor. The antibody is a murine IgG1 with K light chains. It was developed against a crude CBP complex preparation, and its characterization will be reported elsewhere. For immunoblotting, proteins were separated by NaDodSO4/polyacrylamide gel electrophoresis (17) and then transferred to nitrocellulose (Schleicher & Schuell, BA 83) paper by electroblotting according to the procedure of Burnette (18) . To visualize p220, the nitrocellulose sheets were treated sequentially with anti-p220 monoclonal antibody, rabbit anti-mouse IgG, IgA, and IgM antiserum (CalBiochem) and 1251-labeled staphylococcal protein A (Sigma). Radioiodination of protein A was carried out with lodogen beads (Pierce). Monoclonal antibody, rabbit antiserum, or protein A were suspended at >1:1000 dilution in wash solution (5% nonfat dry milk, 0.5 M NaCl, 10 mM Tris HCl, pH 7.4) before use. The induction of rabbit anti-3C antiserum, kindly supplied by B. Semler, has been described (12) . IgG was prepared from this antiserum and from control rabbit antiserum by adsorption to a staphylococcal protein ASepharose (Pharmacia) column (19 (8) . In addition, the antibody reacts only with the corresponding p220 material present in a complete cytoplasmic extract ofuninfected HeLa cells (Fig. LA, lane b) . As expected, this antigen is present in the RSW from uninfected cells (Fig. 1B, lane c) , but no p220 is detectable in RSW from polio-infected cells. As previously reported, smaller presumed cleavage products of p220 (100,000-130,000 Da) are identified by the antibody in the infected cell RSW (Fig. 1B, lane d) . p220 has usually been described as a single polypeptide; however, when analyzed on gels of low percentage acrylamide, up to four polypeptide moieties can be detected with the monoclonal antibody. The immunoblots of infected cell extracts also reveal multiple peptides with common antigenic specificity, with two peptides being major species. Purified CBP complex from HeLa cells also yields multiple p220 protein bands by Coomassie blue protein staining (data not shown). Therefore, the p220 component ofCBP complex appears to exist in several forms, with slightly different mobilities in polyacrylamide gels. Since all the larger peptides are cleaved in infected cells (Fig.  1B) , for the purposes of discussion in this manuscript, they will be collectively referred to as p220.
It has been shown previously that RSW preparations from polio-infected HeLa cells contain an activity that will cleave Proc. Natl. Acad. Sri FJS4. 82 (1985) 2725 exogenous p220 present in RSW prepared from uninfected cells (11) . We have used the immunoblot procedure to assay fractions from infected cells for p220 cleavage activity. Fig.  2 (lanes c-f) shows that infected cell RSW rapidly converts all of the p220 present in an uninfected cell RSW to the characteristic smaller products seen in infected cells. No such activity is present in the corresponding fraction from uninfected cell RSW (lane b).
Poliovirus Protease (Peptide 3C) Does Not Copurify with p220 Cleavage Activity. The immunoblot assay described above was used to localize p220 cleavage activity during initial purification protocols. At the same time, samples were analyzed for the presence ofpoliovirus-specific polypeptides that were specifically radiolabeled during infection prior to preparation of the RSW. In particular, it was of interest to determine whether viral protein 3C, the virus-encoded protease (12, 14) , co-purified with p220 cleavage activity. RSW from infected cells was fractionally precipitated with ammonium sulfate into two fractions (0%-40% saturation, called fraction A; 40%-70% saturation, called fraction B). Immunoblot assay showed fraction A to contain the majority (>90%) of the p220 cleavage activity (data not shown). Therefore, this material was further fractionated by ionexchange chromatography on DEAE-cellulose. All fractions were then analyzed by the immunoblot assay for p220 cleavage activity. Fig. 3A shows that the cleavage activity was detected in the whole cell cytoplasmic extract, the ammonium sulfate fraction A, and in fractions eluting at 0.14-0.18 M KCl (DEAE fractions 4, 5, and 6; lanes h-j). This represents the leading edge of the major peak of total protein that bound to the column (data not shown). Separation of p220 Cleavage Products From the Cleavage Activity. The infected cell RSW used as starting material for the preliminary purification of p220 cleavage activity also contains the pre-existing products of the cleavage reaction that were present in the infected cells. In fact, immunoblot analysis of DEAE column fractions indicated that these antigenically reactive products of 100,000-130,000 Da copurifled with the cleavage activity through DEAE chromatography (data not shown). However, when the pooled fractions from the DEAE column were applied to a phosphocellulose column under low salt conditions, p220 cleavage activity failed to bind and was found in the column flow-through fraction (Fig. 4, lane g ). p220 cleavage products, however, do bind to the resin under these conditions, and they are only eluted when the KCl concentration is increased to 0.1 M (lane d). Resolution of the endogenous cleavage products from the cleavage activity improves the quality of the cleavage assay since both appearance of product as well as disappearance of substrate can be seen on the immunoblots.
Absence of Viral Protease Sequences in p220 Cleavage Fractions. Amino acid sequences in viral protein 3C have been demonstrated to be responsible for the cleavage of poliovirus protein precursors at Gln-Gly residues (12) . Protein 3C is itself processed, perhaps autocatalytically (14) , from precursor proteins 3ABCD (formerly P3-lb) and 3CD (formerly P3-2). In addition, protein 3CD can undergo an alternative cleavage pathway to generate two polypeptides, one of which contains 3C sequences, of no known function.
Since it has not been conclusively demonstrated which of these proteins, all of which contain 3C amino acid sequences, actually catalyzes proteolytic reactions, it was important to determine whether p220 cleavage activity was associated with any proteins comprised of viral 3C sequences. Samples were resolved by NaDodSO4/polyacrylamide gel electrophoresis, transferred to nitrocellulose paper, and then underwent reaction with antiserum raised against protein 3C (12) . Fig. 5 shows that the antiserum reacts with 3C and precursor protein 3CD, as well as with the alternate cleavage product (protein 3C', formerly P3-6a) in poliovirus-infected HeLa cytoplasmic extracts (lane a), and in the ammonium sulfate fraction A (lane b). The DEAE eluate contained no detectable 3C, although some precursor proteins are present (lane c), but no reactive antigens remain in the phosphocellulose flow-through (lane d), which contained peak p220 cleavage activity. The antiserum reacts with two polypeptides (22,000 and 20,000 Da) present in infected cytoplasmic extracts (lanes a and b), the smaller of which comigrates with polypeptide 3C. The larger of these two bands might be a cellular polypeptide that contaminated the immunogen used to raise the antiserum, or it might be a slightly larger precursor to 3C, with additional NH2-terminal viral protein sequences. Effect of Anti-3C IgG on Cleavage of p220 in Vitro. Antibodies from the anti-3C antiserum described above have been shown to inhibit processing of poliovirus precursor proteins synthesized in vitro in an extract from infected HeLa cells (12) . Cleavages at Gln-Gly pairs were specifically inhibited by anti-3C IgG, whereas other cleavages known to occur at Tyr-Gly pairs were unaffected. An infected cell extract was prepared and incubated under protein synthesis conditions in vitro. The synthesis and processing of poliovirus proteins by this extract is shown in Fig. 6A (lane a) . When the extract was preincubated with IgG purified from anti-3C antiserum, the pattern of synthesized proteins changed markedly (Fig. 6A,  lanes d and e) . The majority of synthesized protein remained large, and the appearance of almost all cleavage products was inhibited (e.g., see arrows in Fig. 6A indicating cleavage products 2BC and 2C). Of notable exception is polypeptide 3D', whose formation appears to be enhanced; this polypeptide results from a Tyr-Gly cleavage, not inhibited by anti-3C IgG (12) . A small amount of RSW that contained intact p220 from uninfected HeLa cells was included in the translation reactions. Fig. 6B (lanes d and e) shows that cleavage of p220 occurred completely in the same reaction in which cleavage of poliovirus precursor protein was inhibited. This result further demonstrates that cleavage of p220 is not directly affected by the viral protease that processes viral proteins. IgG on p220 cleavage in vitro. Samples (15 pA) of translation reactions were analyzed for p220 and p220 breakdown products as described in the legend to Fig. 2. Translation reactions electroblotted (lanes a-f) were the same as described above. RSW from uninfected cells (5 pI) is shown in lane R.
24,000-Da CBP I is dissociated, or unstable to standard purification procedures, in infected cells (10) ; it has also been demonstrated that the p220 component of the CBP complex is cleaved in infected cells (11) . If proteolysis of p220 is the direct event responsible for inactivation of cap-dependent protein synthesis after poliovirus infection, it seemed reasonable to test the hypothesis that the known poliovirus-encoded protease was the mediator of p220 cleavage. The cleavage site specificity of the viral protease appears to involve stringent recognition of Gln-Gly pairs in the substrate. The site(s) of cleavage in p220 have not been identified.
We have used an immunoblot technique to detect the cleavage of p220 in vitro, by fractions from poliovirusinfected HeLa cell lysates. This assay enabled us to partially purify the cleavage activity in infected cells and to demonstrate that the cleavage activity separates from radiolabeled viral protease 3C at an early step in purification. Immunoblotting with specific antibody against the viral protease corroborated these data and also eliminated the possibility that protease precursors (3CD) or related polypeptides (3C') were alternative mediators of p220 cleavage.
Fractions that were markedly enriched for viral protease 3C had no detectable p220 cleavage activity. Although it was not possible to demonstrate that these fractions were active on poliovirus precursor proteins because of unavailability of substrate, it was possible to inhibit the action of the viral protease in an infected cell translation system with IgG prepared from anti-3C antiserum. Under these conditions, cleavage of p220 was not affected. Thus, by this criterion as well, viral 3C sequences are not involved in the cleavage of the p220 component of the CBP complex.
The identity of the mediator of p220 cleavage remains in question. No major poliovirus proteins clearly copurify with the cleavage activity (data not shown), but neither a weakly labeled viral protein nor a cellular protein that is altered or activated by poliovirus infection can be excluded at this time. If the latter is the case, the viral protease could play a role in the activation and, thus, might be indirectly involved in the translational regulation observed in infected cells.
Despite the relatively small size of the poliovirus genome, only the P1 and P3 regions, representing the 5' and 3' segments of the coding sequence, have been assigned gene products with known functions. Proteins encoded by the middle region have no identified functions and, thus, can still be considered candidates for p220 cleavage activity.
